Vascular Solutions Inc. (NASDAQ:VASC) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $47.84 and last traded at $47.74, with a volume of 49,266 shares. The stock had previously closed at $47.19.

Several equities research analysts have recently issued reports on VASC shares. Zacks Investment Research downgraded shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, June 29th. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Canaccord Genuity restated a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. Piper Jaffray Cos. raised their price objective on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 26th. Finally, Sidoti downgraded shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target on the stock. in a research note on Tuesday, July 12th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Vascular Solutions currently has an average rating of “Buy” and a consensus price target of $47.38.

The firm has a 50 day moving average price of $45.51 and a 200-day moving average price of $37.41. The firm has a market cap of $835.02 million and a PE ratio of 88.41.

Vascular Solutions (NASDAQ:VASC) last announced its earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.30 by $0.03. The company had revenue of $41.20 million for the quarter, compared to analysts’ expectations of $41.40 million. The firm’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.29 EPS. Analysts forecast that Vascular Solutions Inc. will post $1.24 EPS for the current fiscal year.

In related news, VP William Rutstein sold 10,011 shares of Vascular Solutions stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total transaction of $463,108.86. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Howard Root sold 40,000 shares of Vascular Solutions stock in a transaction that occurred on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total value of $1,804,400.00. Following the transaction, the chief executive officer now directly owns 347,840 shares in the company, valued at approximately $15,691,062.40. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Vascular Solutions stock. Schwab Charles Investment Management Inc. raised its position in Vascular Solutions Inc. (NASDAQ:VASC) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,929 shares of the medical device company’s stock after buying an additional 1,892 shares during the period. Schwab Charles Investment Management Inc. owned 0.33% of Vascular Solutions worth $1,958,000 at the end of the most recent reporting period.

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.